Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Clinical trial NCT03372993 · COMPLETED

Trial details

NCT number: NCT03372993
Sponsor: AryoGen Pharmed Co.
Status: COMPLETED
Study type: OBSERVATIONAL

Hemophilia A With Inhibitor Hemophilia B With Inhibitor Factor VII Deficiency Glanzmann's Thrombasthenia

Start date: 2016-06-13
Primary completion: 2021-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.